Literature DB >> 14631207

Human malformation syndromes due to inborn errors of cholesterol synthesis.

Forbes D Porter1.   

Abstract

PURPOSE OF REVIEW: This review covers a group of human malformation syndromes, which are caused by inborn errors of cholesterol synthesis. The Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive, multiple malformation, and mental retardation syndrome that is the prototypical example of this group of disorders. In the 10 years since the biochemical cause of SLOS was identified, other malformation syndromes have been shown to result from defects in this pathway. These include desmosterolosis, lathosterolosis, X-linked dominant chondrodysplasia punctata type 2 (CDPX2), congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD syndrome), hydrops-ectopic calcification-moth-eaten skeletal dysplasia (HEM dysplasia), and some cases of Antley-Bixler syndrome. These disorders represent the first true merging of dysmorphology with biochemical genetics. RECENT
FINDINGS: Recent studies report the identification of human lathosterolosis patients, indicate that SLOS is a relatively common genetic disorder that may be a major unrecognized cause of fetal loss, suggest that correction of the biochemical defect can improve central nervous system function, and show that perturbed sonic hedgehog signaling due to decreased sterol levels likely underlies some of the malformations in SLOS and lathosterolosis.
SUMMARY: Recognition of the biochemical defect in these syndromes has given insight into the role that cholesterol plays during normal development, into understanding the pathophysiological processes that underlie the clinical problems found in these disorders, and into developing therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631207     DOI: 10.1097/00008480-200312000-00011

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  48 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

Review 2.  The ins and outs of cholesterol in the vertebrate retina.

Authors:  Steven J Fliesler; Lionel Bretillon
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

Review 3.  SHH pathway and cerebellar development.

Authors:  Catherine Vaillant; Denis Monard
Journal:  Cerebellum       Date:  2009-02-18       Impact factor: 3.847

4.  Multiple malformations: a possible Sonic hedgehog phenotype?

Authors:  Helen Wainwright; Peter Beighton
Journal:  Virchows Arch       Date:  2009-02-10       Impact factor: 4.064

5.  Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Wei Liu; Lowell G Sheflin; Steven J Fliesler; Ned A Porter
Journal:  J Lipid Res       Date:  2011-08-04       Impact factor: 5.922

6.  Lethal epiphyseal stippling in the foetus and neonate; pathological implications.

Authors:  Helen Wainwright; Peter Beighton
Journal:  Virchows Arch       Date:  2010-03       Impact factor: 4.064

Review 7.  Pathogenesis-based therapies in ichthyoses.

Authors:  Joey E Lai-Cheong; Peter M Elias; Amy S Paller
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

8.  Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells.

Authors:  Libin Xu; Zeljka Korade; Dale A Rosado; Karoly Mirnics; Ned A Porter
Journal:  J Lipid Res       Date:  2013-02-04       Impact factor: 5.922

9.  Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Josep Marcos; Cedric H L Shackleton; Madhavee M Buddhikot; Forbes D Porter; Gordon L Watson
Journal:  Steroids       Date:  2007-07-13       Impact factor: 2.668

10.  Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Kathleen Boesze-Battaglia; Monika Damek-Poprawa; Drake C Mitchell; Laura Greeley; Richard S Brush; Robert E Anderson; Michael J Richards; Steven J Fliesler
Journal:  J Lipid Res       Date:  2008-03-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.